Clinical Trial Update: Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results update for palbociclib in combination with fulvestrant or letrozole in ER-positive, HER2-negative metastatic breast cancer; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: MedSIR | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-12-09